跳至主要内容
临床试验/NCT00853528
NCT00853528已完成1 期

Cyberknife Radiosurgery for Improving Palliation of Metastatic Tumors of the Spine

Boston Medical Center2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2009年1月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
18
试验地点
2
主要终点
Maximum tolerated dose - hypofraction

研究概览

简要总结

RATIONALE: Stereotactic radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue. It may also help patients with spinal metastases live more comfortably.

PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiosurgery in treating patients with spinal metastases.

详细描述

OBJECTIVES:

  • To implement CyberKnife® technology for improving palliation in patients with spinal metastases.
  • To determine the maximum tolerated dose of CyberKnife® hypofractionated stereotactic radiosurgery in these patients.
  • To evaluate functional and diffusion MRI parameters in the spinal cord and tumor after treatment with Cyberknife® radiosurgery.

OUTLINE: Patients undergo placement of gold fiducial markers at the time of open surgical resection or percutaneous needle biopsy. Patients then undergo CyberKnife® hypofractionated stereotactic radiosurgery over 30-90 minutes daily for 2-3 days.

Patients undergo functional MRI and diffusion tensor imaging at baseline and then at 6 weeks and 6 months after completion of treatment. Patients also complete a pain questionnaire at baseline and then at 3, 6, 9, 12, 18, and 24 months after completion of treatment.

After completion of study treatment, patients are followed periodically for up to 2 years.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed metastatic spinal tumor
  • Localized spinal metastasis, defined as one of the following:
  • Solitary spinal metastasis
  • Two contiguous spinal levels
  • No more than 2 adjacent spinal levels involved by a single tumor
  • Involvement of ≤ 3 separate sites (e.g., C5, T5, and T12)
  • Tumor size ≤ 5 cm
  • PATIENT CHARACTERISTICS:
  • Karnofsky performance status 60-100%
  • Life expectancy ≥ 6 months
  • Negative pregnancy test
  • Fertile patients must use effective contraception
  • Must be ambulatory

排除标准

  • Not pregnant or nursing
  • No spinal instability
  • No rapid neurological decline
  • No bony retropulsions causing neurological abnormalities
  • No total paraplegia for > 48 hours
  • No psychological issues that would preclude completion of study treatment
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior treatment for spinal tumor that would result in potential overlap of radiotherapy fields
  • No treatment that is expected to exceed spinal cord tolerance or other regional normal tissue tolerance
  • No tumors that are exquisitely radiosensitive and controlled with conventional radiotherapy (e.g., lymphoma, leukemia, multiple myeloma, or germ cell tumors)

研究组 & 干预措施

Single-fraction radiosurgery; 16 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 16 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: questionnaire administration (Other)

Single-fraction radiosurgery; 16 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 16 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: diffusion tensor imaging (Procedure)

Single-fraction radiosurgery; 16 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 16 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: functional magnetic resonance imaging (Procedure)

Single-fraction radiosurgery; 16 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 16 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: single-fraction SRS (Radiation)

Hypo-fractionated radiosurgery; 21 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 21 Gray

干预措施: questionnaire administration (Other)

Hypo-fractionated radiosurgery; 21 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 21 Gray

干预措施: diffusion tensor imaging (Procedure)

Hypo-fractionated radiosurgery; 21 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 21 Gray

干预措施: functional magnetic resonance imaging (Procedure)

Hypo-fractionated radiosurgery; 21 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 21 Gray

干预措施: hypo-fractionated SRS (Radiation)

Single-fraction radiosurgery; 18 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 18 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: questionnaire administration (Other)

Single-fraction radiosurgery; 18 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 18 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: diffusion tensor imaging (Procedure)

Single-fraction radiosurgery; 18 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 18 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: functional magnetic resonance imaging (Procedure)

Single-fraction radiosurgery; 18 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 18 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: single-fraction SRS (Radiation)

Single-fraction radiosurgery; 20 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 20 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: questionnaire administration (Other)

Single-fraction radiosurgery; 20 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 20 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: diffusion tensor imaging (Procedure)

Single-fraction radiosurgery; 20 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 20 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: functional magnetic resonance imaging (Procedure)

Single-fraction radiosurgery; 20 Gray

Experimental

Subjects able to achieve the spinal cord dose constraints for single-fraction SRS stereotactic radiosurgery Radiation: stereotactic radiotherapy at 20 Gray Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging

干预措施: single-fraction SRS (Radiation)

Hypo-fractionated radiosurgery; 24 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 24 Gray

干预措施: questionnaire administration (Other)

Hypo-fractionated radiosurgery; 24 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 24 Gray

干预措施: diffusion tensor imaging (Procedure)

Hypo-fractionated radiosurgery; 24 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 24 Gray

干预措施: functional magnetic resonance imaging (Procedure)

Hypo-fractionated radiosurgery; 24 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 24 Gray

干预措施: hypo-fractionated SRS (Radiation)

Hypo-fractionated radiosurgery; 27 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 27 Gray

干预措施: questionnaire administration (Other)

Hypo-fractionated radiosurgery; 27 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 27 Gray

干预措施: diffusion tensor imaging (Procedure)

Hypo-fractionated radiosurgery; 27 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 27 Gray

干预措施: functional magnetic resonance imaging (Procedure)

Hypo-fractionated radiosurgery; 27 Gray

Experimental

Subjects unable to achieve the spinal cord dose constraints for single-fraction radiosurgery (SRS), based on tumor location and expected tolerance dose to the adjacent normal tissue, will be offered hypo-fractionated SRS (3 fractions) Radiation: stereotactic radiotherapy Questionnaire administration diffusion tensor imaging functional magnetic resonance imaging hypo-fractionated radiation therapy at 27 Gray

干预措施: hypo-fractionated SRS (Radiation)

结局指标

主要结局

Maximum tolerated dose - hypofraction

时间窗: 6 weeks

Maximum tolerated dose of CyberKnife® hypofractionated stereotactic radiosurgery

Maximum tolerated dose - single fraction

时间窗: 6 weeks

Maximum tolerated dose of CyberKnife® hypofractionated stereotactic radiosurgery

次要结局

  • Spinal cord response(baseline and then at 6 weeks and 6 months after completion of treatment)
  • Assessment of pain(baseline and then at 3, 6, 9, 12, 18, and 24 months after completion of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Minh Tam Truong

BMC Attending Physician

Boston Medical Center

研究点 (2)

Loading locations...

相似试验

终止
不适用
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerLung Cancer
NCT00852644Boston Medical Center9
已完成
不适用
Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerHead and Neck Cancer
NCT00851253Boston Medical Center12
已完成
2 期
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological MalignanciesFallopian Tube CancerOvarian SarcomaOvarian Stromal CancerRecurrent Cervical CancerRecurrent Endometrial CarcinomaRecurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorRecurrent Uterine SarcomaRecurrent Vaginal CancerRecurrent Vulvar CancerStage III Cervical CancerStage III Endometrial CarcinomaStage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage III Uterine SarcomaStage III Vaginal CancerStage III Vulvar CancerStage IV Endometrial CarcinomaStage IV Ovarian Epithelial CancerStage IV Ovarian Germ Cell TumorStage IV Uterine SarcomaStage IV Vulvar CancerStage IVA Cervical CancerStage IVA Vaginal CancerStage IVB Cervical CancerStage IVB Vaginal Cancer
NCT01079832Case Comprehensive Cancer Center50
已完成
2 期
Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
NCT00006456Virginia Commonwealth University26
终止
不适用
Stereotactic Radiation Therapy in Treating Patients With Prostate CancerProstate Cancer
NCT00619515Case Comprehensive Cancer Center73